These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30864396)

  • 1. Functions of adiponectin signaling in regulating neural plasticity and its application as the therapeutic target to neurological and psychiatric diseases.
    Sun LN; Liu XL
    Rev Neurosci; 2019 Jul; 30(5):485-495. PubMed ID: 30864396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting BDNF signaling by natural products: Novel synaptic repair therapeutics for neurodegeneration and behavior disorders.
    Bawari S; Tewari D; Argüelles S; Sah AN; Nabavi SF; Xu S; Vacca RA; Nabavi SM; Shirooie S
    Pharmacol Res; 2019 Oct; 148():104458. PubMed ID: 31546015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crosstalk of metabolic factors and neurogenic signaling in adult neurogenesis: Implication of metabolic regulation for mental and neurological diseases.
    Gao C; Wang Q; Chung SK; Shen J
    Neurochem Int; 2017 Jun; 106():24-36. PubMed ID: 28188802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-derived neurotrophic factor mechanisms and function in adult synaptic plasticity: new insights and implications for therapy.
    Kuipers SD; Bramham CR
    Curr Opin Drug Discov Devel; 2006 Sep; 9(5):580-6. PubMed ID: 17002218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutamate Signaling in Synaptogenesis and NMDA Receptors as Potential Therapeutic Targets for Psychiatric Disorders.
    Ohgi Y; Futamura T; Hashimoto K
    Curr Mol Med; 2015; 15(3):206-21. PubMed ID: 25817855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Part 1. Basic approaches and perspectives.
    Handb Exp Pharmacol; 2015; 228():1-3. PubMed ID: 26317139
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular psychiatry. Adaptations of receptor-coupled signal transduction pathways underlying stress- and drug-induced neural plasticity.
    Duman RS; Heninger GR; Nestler EJ
    J Nerv Ment Dis; 1994 Dec; 182(12):692-700. PubMed ID: 7989913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders.
    Mattson MP; Shea TB
    Trends Neurosci; 2003 Mar; 26(3):137-46. PubMed ID: 12591216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CREB: A Promising Therapeutic Target for Treating Psychiatric Disorders.
    Guan W; Ni MX; Gu HJ; Yang Y
    Curr Neuropharmacol; 2024; 22(14):2384-2401. PubMed ID: 38372284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiation and adaptation: a paradigm for understanding psychotropic drug action.
    Hyman SE; Nestler EJ
    Am J Psychiatry; 1996 Feb; 153(2):151-62. PubMed ID: 8561194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of mGlu Receptors in Hippocampal Plasticity Deficits in Neurological and Psychiatric Disorders: Implications for Allosteric Modulators as Novel Therapeutic Strategies.
    Senter RK; Ghoshal A; Walker AG; Xiang Z; Niswender CM; Conn PJ
    Curr Neuropharmacol; 2016; 14(5):455-73. PubMed ID: 27296640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of adult hippocampal neurogenesis in cognition in physiology and disease: pharmacological targets and biomarkers.
    Costa V; Lugert S; Jagasia R
    Handb Exp Pharmacol; 2015; 228():99-155. PubMed ID: 25977081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Roles of BAI Adhesion-GPCRs in Synapse Development and Plasticity.
    Duman JG; Tu YK; Tolias KF
    Neural Plast; 2016; 2016():8301737. PubMed ID: 26881134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotrophic factors in autonomic nervous system plasticity and dysfunction.
    Mattson MP; Wan R
    Neuromolecular Med; 2008; 10(3):157-68. PubMed ID: 18172785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Adiponectin in Central Nervous System Disorders.
    Bloemer J; Pinky PD; Govindarajulu M; Hong H; Judd R; Amin RH; Moore T; Dhanasekaran M; Reed MN; Suppiramaniam V
    Neural Plast; 2018; 2018():4593530. PubMed ID: 30150999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signaling pathways relevant to cognition-enhancing drug targets.
    Ménard C; Gaudreau P; Quirion R
    Handb Exp Pharmacol; 2015; 228():59-98. PubMed ID: 25977080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid rafts, synaptic transmission and plasticity: impact in age-related neurodegenerative diseases.
    Sebastião AM; Colino-Oliveira M; Assaife-Lopes N; Dias RB; Ribeiro JA
    Neuropharmacology; 2013 Jan; 64():97-107. PubMed ID: 22820274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin Role in Neurodegenerative Diseases: Focus on Nutrition Review.
    Polito R; Di Meo I; Barbieri M; Daniele A; Paolisso G; Rizzo MR
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging.
    Duda P; Wiśniewski J; Wójtowicz T; Wójcicka O; Jaśkiewicz M; Drulis-Fajdasz D; Rakus D; McCubrey JA; Gizak A
    Expert Opin Ther Targets; 2018 Oct; 22(10):833-848. PubMed ID: 30244615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of neurotrophic factors in behavioral processes: implications for the treatment of psychiatric and neurodegenerative disorders.
    Pardon MC
    Vitam Horm; 2010; 82():185-200. PubMed ID: 20472139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.